6. Antifungal activity of nanomaterials
Numerous teams have studied the antibacterial effects of nanoparticles, but there are few studies concerning antifungal effects. Unlike bacteria, which are single-cell prokaryotic organisms, fungi are eukaryotic organisms and can be unicellular or multicellular. The number of drugs available to treat fungal diseases is relatively limited, and there is a growing demand for the development of new treatments. The antifungal drugs currently used to treat fungal diseases, such as those caused by C. albicans, are directed against multiple targets: the fungal wall, plasma membranes, DNA, RNA, proteins involved in ergosterol synthesis, etc. The most widely used drugs to treat fungal diseases are those used to treat C. albicans. The drugs most commonly used to treat fungal infections are polyenes and azoles. The literature is full of evidence of the resistance of fungal strains to these two groups...
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference
This article is included in
Drugs and pharmaceuticals
This offer includes:
Knowledge Base
Updated and enriched with articles validated by our scientific committees
Services
A set of exclusive tools to complement the resources
Practical Path
Operational and didactic, to guarantee the acquisition of transversal skills
Doc & Quiz
Interactive articles with quizzes, for constructive reading
Antifungal activity of nanomaterials
Bibliography
Websites
In 2002, the European Union set up the 6th Framework Program called Nano2Life. http://www.nano2life.org
Among the national networks, we should mention "C'NANO Île-de-France". http://www.cnanoidf.org/
Other advisor leads.
Exclusive to subscribers. 97% yet to be discovered!
You do not have access to this resource.
Click here to request your free trial access!
Already subscribed? Log in!
The Ultimate Scientific and Technical Reference